meglumine has been researched along with Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Enomoto, T; Hagiwara, O; Matsukiyo, H; Moriyama, H; Sato, E; Sato, Y; Takeda, K; Watanabe, M; Yoshida, R; Yoshida, S; Yoshioka, K | 1 |
Balvay, D; Clement, O; Cuenod, CA; Espinoza, S; Fournier, LS; Kachenoura, N; Thomassin-Naggara, I | 1 |
Ghezzi, C | 1 |
1 trial(s) available for meglumine and Neoplasms
Article | Year |
---|---|
[Studies on the analgesic effect of meglumine indomethacinate in neoplasms].
Topics: Analgesics; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Indomethacin; Male; Meglumine; Neoplasms; Pain | 1976 |
2 other study(ies) available for meglumine and Neoplasms
Article | Year |
---|---|
Whole cancer-region enhancement using meglumine-gadopentetate-glucose solution and 7.0-T magnetic resonance imaging.
Topics: Contrast Media; Gadolinium DTPA; Glucose; Humans; Magnetic Resonance Imaging; Meglumine; Neoplasms; Organometallic Compounds; Pentetic Acid | 2021 |
Signal-to-noise ratio improvement in dynamic contrast-enhanced CT and MR imaging with automated principal component analysis filtering.
Topics: Contrast Media; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Neoplasms; Organometallic Compounds; Principal Component Analysis; Statistics, Nonparametric; Tomography, X-Ray Computed | 2011 |